PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
